Skip to main content

Advertisement

Log in

Investigating the causes of vertigo in breast cancer survivors

  • Miscellaneous
  • Published:
European Archives of Oto-Rhino-Laryngology and Head & Neck Aims and scope Submit manuscript

Abstract

The vertigo symptom in breast cancer survivors has rarely been mentioned. The aim of this study was to investigate the causes of vertigo in breast cancer survivors with vertigo. From May 1997 to April 2003, 36 consecutive female breast cancer survivors with vertigo underwent a battery of tests including physical examination, neurological examination, serum lipid profile, plain chest radiograph, whole body bone scan, liver sonography, audiometry, electronystagmography (ENG) and MRI scan. Based on these tests, the causes of vertigo were attributed to peripheral labyrinthine origin in 14 patients (39%) and central origin in 22 patients (61%) consisting of 11 cases of vascular insufficiency, eight of hyperlipidemia and three of posterior fossa metastases (8%). The latter included one case of cerebellopontine angle and two of cerebellum, accompanied by extracranial systemic metastases, e.g., of the lung, bone or liver. In conclusion, vertigo in breast cancer survivors warrants concern, especially in those with extra-cranial systemic metastasis accompanied by headache. In addition to 8% occurrence of posterior fossa metastasis, other possible causes for vertigo in breast cancer survivors consist of vascular insufficiency, hyperlipidemia and labyrinthine lesion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Boogerd W, Vos VW, Hart AAM, Baris G (1993) Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurol-Oncol 15:165–174

    Google Scholar 

  2. Schouten LJ, Rutten J, Huveneers HAM, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94:2698–2705

    Article  PubMed  Google Scholar 

  3. Graf AH, Buchberger W, Langmayr H, Schmid KW (1988) Site preference of metastatic tumors of the brain. Virchows Arch Pathol Anat Histopathol 412:493–498

    CAS  Google Scholar 

  4. Walker AE, Robins M, Weinfeld FD (1985) Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35:219–226

    CAS  PubMed  Google Scholar 

  5. Streitmann MJ, Sismanis A (1996) Metastatic carcinoma of the temporal bone. Am J Otol 17:780–783

    CAS  PubMed  Google Scholar 

  6. Wronski M, Arbit E, McCormick B (1997) Surgical treatment of 70 patients with brain metastases from breast carcinoma. Cancer 80:1746–1754

    Article  CAS  PubMed  Google Scholar 

  7. Huang TW, Young Y-H (2002) Differentiation of cerebellopontine angle tumors in cancer patients. Otol Neurotol 23:975–979

    Article  PubMed  Google Scholar 

  8. Gloria-Cruz TI, Schachern PA, Paparella MM, Adams GL, Fulton SE (2000) Metastases to temporal bones from primary nonsystematic malignant neoplasms. Arch Otolaryngol Head Neck Surg 126:209–214

    CAS  PubMed  Google Scholar 

  9. Kiricuta IC, Kolbl O, Willner J, Bohndorf W (1992) Central nervous system metastases in breast cancer. J Cancer Res Clin Oncol 118:542–546

    CAS  PubMed  Google Scholar 

  10. Viadana E, Bross ID, Pickren JW (1973) An autopsy study of some routes of dissemination of cancer of the breast. Br J Cancer 27:336–340

    CAS  PubMed  Google Scholar 

  11. Zee DS (1984) New concept of cerebellar control of eye movements. Otolaryngol Head Neck Surg 92:59–62

    CAS  PubMed  Google Scholar 

  12. Alexopoulos CG, Blatsios B, Avgerinos A (1987) Serum lipids and lipoprotein disorders in cancer patients. Cancer 60:3065–3070

    CAS  PubMed  Google Scholar 

  13. De Waard F (1975) Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res 35:3351–3356

    PubMed  Google Scholar 

  14. Miller AB, Kelly A, Choi NW, Matthews V, Morgan RW, Munan L, Burch JD, Feather J, Howe GR, Jain M (1978) A study of diet and breast cancer. Am J Epidemiol 107:499–509

    CAS  PubMed  Google Scholar 

  15. Rossner S, Wallgren A (1984) Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen. Atherosclerosis 52:339–346

    CAS  PubMed  Google Scholar 

  16. Glueck CJ, Fallat RW, Schell D (1975) Effects of estrogenic compounds on triglyceride kinetics. Metabolism 24:537–545

    Article  CAS  PubMed  Google Scholar 

  17. Applebaum DM, Goldberg AP, Pykalisto OJ, Brunzell JD, Hazzard WR (1977) Effect of estrogen on post-heparin lipolytic activity: selective decline in hepatic triglyceride lipase. J Clin Invest 59:601–608

    CAS  PubMed  Google Scholar 

  18. Brun LD, Gagne C, Rousseau C, Moorjani S, Lupien PJ (1986) Severe lipemia induced by tamoxifen. Cancer 57:2123–2126

    CAS  PubMed  Google Scholar 

  19. Kanel KT, Thompson PD (1997) Delayed severe hypertriglyceridemia from tamoxifen. New Engl J Med 337:281–282

    Article  CAS  Google Scholar 

  20. Joensuu H, Holli K, Oksanen H, Valavaara R (2000) Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer. Breast Cancer Res Tr 63:225–234

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was made possible by grant no. NSC 92-2314-B002-349 from the National Science Council, Taipei, Taiwan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yi-Ho Young.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, ZM., Young, YH. Investigating the causes of vertigo in breast cancer survivors. Eur Arch Otorhinolaryngol 262, 432–436 (2005). https://doi.org/10.1007/s00405-004-0846-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-004-0846-5

Keywords

Navigation